In this episode of Stuff You Should Know, the hosts explore Lyme disease, a tick-borne illness caused by the bacterium Borrelia burgdorferi. The discussion covers how this pathogen evades the immune system through rapid protein changes, the challenges of early diagnosis due to antibody detection delays, and why the distinctive bull's-eye rash appears in only 70-80% of cases. The episode also addresses Post-Treatment Lyme Disease Syndrome, where patients experience persistent symptoms despite negative tests.
Beyond medical aspects, the hosts examine the disease's spread across the United States. They address conspiracy theories linking Lyme to government bioweapons research, contrasting these claims with evidence pointing to climate change as the primary driver of tick population expansion. The episode also highlights the 1970s Connecticut outbreak and the patient advocates whose persistence led to the disease's identification by researcher Willy Bergdorfer.

Sign up for Shortform to access the whole episode summary along with additional materials like counterarguments and context.
Lyme disease is caused by the bacterium Borrelia burgdorferi, transmitted primarily through nymph-stage black-legged tick bites. These nymphs are particularly dangerous because their small size makes them difficult to detect. The bacteria require 24-36 hours of tick attachment to migrate from the tick's mid-gut to its saliva and eventually into the human bloodstream. Once inside the body, these highly mobile spirochetes travel through blood and infiltrate various tissues, causing widespread damage.
What makes Borrelia burgdorferi especially challenging is its remarkable ability to evade the immune system. Recent research reveals the bacterium can change its protein expression 15 times faster than typical bacteria. This rapid modification allows it to outpace the body's antibody production—antibodies targeting the initial form become ineffective as the bacterium alters its surface proteins, allowing the infection to persist and spread.
Primary symptoms include fever, headaches, fatigue, and joint pain. The most recognizable sign is the expanding erythema migrans rash, often appearing as a bull's-eye pattern within a week of infection. However, this telltale rash appears in only 70-80% of cases. Without this distinctive marker, symptoms easily mimic other illnesses, leading to frequent misdiagnosis or treatment delays as doctors attribute generic symptoms to various other conditions.
Diagnostic tests don't detect the bacterium directly but instead measure antibodies, creating a significant problem. Clark notes that it can take days or weeks for antibodies to reach detectable levels, meaning early testing often produces false negatives. Additionally, the bacterium moves rapidly out of the bloodstream into tissues, making direct detection challenging. Current guidelines recommend two-tiered testing to improve accuracy—an initial antibody test followed by a Western blot confirmation.
Clark explains that early-stage Lyme responds well to two-to-four-week antibiotic courses, proving effective approximately 90% of the time when caught early. In endemic areas, physicians often prescribe prophylactic antibiotics after tick bites, even before infection is confirmed.
However, a significant subset of patients report persistent symptoms—fatigue, headaches, joint pain, and cognitive issues—for months or years after treatment. This cluster of ongoing issues is known as Post-Treatment Lyme Disease Syndrome (PTLDS). Patients experiencing PTLDS often feel dismissed when doctors cite negative test results. Some believe standard antibiotic courses are insufficient and that spirochetes persist in hard-to-reach tissues. Alternative explanations include lingering immune responses to bacterial fragments or post-infectious autoimmune disorders. These possibilities remain debated, fueling mistrust and patient distress. Both Bryant and Clark stress the importance of patient self-advocacy, especially in endemic areas.
A conspiracy theory alleges that Lyme disease began as government bioweapons research that escaped from labs in Fort Detrick, Maryland, and Plum Island, New York. Newby's book details alleged research into ticks as bioweapon delivery systems, suggesting infected ticks escaped on migrating birds. Rep. Chris Smith even introduced legislation requesting a Department of Defense review, amplifying the theory's reach.
However, substantial evidence contradicts this narrative. The 5,300-year-old mummy Ötzi was found infected with Borrelia burgdorferi, and Yale researchers identified the bacterium in ancient North America dating back 60,000 years. Additionally, cases appeared simultaneously in disparate locations—California, Wisconsin, and Connecticut—inconsistent with a single lab release. Bryant notes the theory's impracticality: the disease is slow-acting and requires multiple unreliable contingencies to work as a weapon.
A more substantiated explanation lies in climate change. The EPA officially lists Lyme's spread as a climate change indicator. Warmer winters allow more ticks to survive, driving their expansion north and into previously unaffected regions. Lyme cases now occur in all lower 48 states, with half of U.S. counties considered high-risk. The deer population boom in the Northeast, resulting from reduced predator populations, provides abundant tick hosts. Experts now recommend reintroducing wolves and mountain lions to control deer and tick numbers.
Unchecked tick growth is causing severe ecological damage. In Wisconsin and the Dakotas, moose are dying from infestations of thousands of ticks, a phenomenon rarely seen before recent decades. With over 300,000 Americans contracting Lyme disease annually, mitigation efforts are increasingly urgent.
In the 1970s, a cluster of unusual illnesses appeared in Connecticut towns—swollen knees, rashes, headaches, and severe fatigue. Medical professionals, unaware of this emerging disease, frequently dismissed concerned patients rather than admit their uncertainty.
Two patient advocates, Polly Murray and Judith Minch—both mothers with affected family members—independently researched and compiled evidence. Murray created a list of 37 patients with similar symptoms. Despite facing gender-based discrimination, they persisted, taking their case to Yale Medical School and Connecticut state health authorities. Their advocacy succeeded in escalating the issue to the scientific community, making it impossible to ignore. Murray's work culminated in her 1996 book "The Widening Circle."
Thanks to their efforts, researcher Willy Bergdorfer—the world's leading authority on Rocky Mountain spotted fever—investigated the outbreak. Murray and Minch had established that nearly every sick person recalled a tick bite and distinctive rash before symptoms began. Bergdorfer hypothesized a previously unrecognized tick-borne bacterium was responsible. He discovered a spirochete bacterium in patient specimens, and the bacterium was named Borrelia burgdorferi in his honor. However, the medical establishment's initial overconfidence in antibiotic treatment led to premature victory declarations, ignoring persistent symptoms that fueled ongoing controversy over chronic Lyme disease.
1-Page Summary
Lyme disease is caused by the bacterium Borrelia burgdorferi, which is transmitted to humans primarily through the bite of a nymph-stage black-legged tick, also known as the deer tick. Nymphs are especially problematic because of their small size, making them difficult to spot on the body, increasing the chance of undetected attachment.
For transmission to occur, the infected tick needs to be attached to the host for approximately 24–36 hours, sometimes longer. During this period, the bacteria move from the tick’s mid-gut to its saliva, eventually entering the human bloodstream. Removing a tick before this window significantly reduces the risk of contracting Lyme disease.
Once in the human body, Borrelia burgdorferi spirochetes are highly mobile. They travel through the bloodstream and infiltrate various tissues, causing widespread disruption and damage as they attack the body.
Recent research highlights that Borrelia burgdorferi can change its protein expression 15 times faster than the average mutation rate for bacteria. This rapid modification allows it to persistently evade the body's immune response.
The body produces antibodies targeting the spirochete based on its initial form. However, because the bacterium swiftly alters its surface proteins, these antibodies may no longer recognize or bind to the bacterium, rendering the immune response ineffective. As a result, the infection can persist and spread throughout the body.
Primary symptoms of Lyme disease include fever, headaches, fatigue, and joint pain. The most recognizable sign is an expanding erythema migrans (EM) rash, often manifesting as a circular, bull’s-eye pattern within about a week of infection.
Lyme Disease: Tick-Borne Spirochete Transmission and Immune Evasion
Diagnostic tests for Lyme disease do not detect the Borrelia burgdorferi bacterium directly. Instead, they measure antibodies the immune system produces in response to infection. Josh Clark notes that this creates a significant problem: it can take days or even weeks for the body to generate antibodies at detectable levels. If a test is administered shortly after a tick bite, especially within the first few days, it may result in a false negative because the immune response is not yet measurable—even if the person is infected.
Another difficulty is that even tests designed to find Borrelia burgdorferi in the blood have a narrow window of effectiveness. The bacterium moves out of the bloodstream rapidly, embedding in tissues soon after infection, so direct detection is often unsuccessful if not timed perfectly.
To improve accuracy and reduce false positives, current guidelines advocate for two-tiered testing. If initial antibody tests are positive, a follow-up Western blot is recommended. This test looks for antibodies more specific to Borrelia burgdorferi, increasing diagnostic confidence.
Treatment protocols established since the 1990s indicate that early-stage Lyme disease responds well to a two-to-four-week course of oral antibiotics. Clark explains that if Lyme is caught early, this approach is effective approximately 90% of the time. The telltale bull’s-eye rash is considered a clear indicator that prompts timely treatment.
There is enough confidence in the effectiveness of antibiotics for early Lyme that, in endemic areas, physicians often prescribe a prophylactic round of antibiotics if a patient presents with a tick attached to the skin—even before infection is confirmed. This aims to eliminate potential disease before symptoms even arise.
While most people recover completely, a significant subset report persistent symptoms—such as fatigue, headaches, joint pain, and cognitive issues—for months or years after treatment. This cluster of ongoing issues is known as Post-Treatment Lyme Disease Syndrome (PTLDS), or chronic Lyme.
Patients experiencing PTLDS often feel dismissed, as doctors will cite negative test results and insist that the infection has been eradicated. This disconnect breeds frustration within the Lyme community. Some patient activists believe standard antibiotic courses are insufficient and that Borrelia spirochetes may persist in hard-to-reach tissues, possibly changing form to evade detection.
Alternative explanations for persistent symptoms include the presence ...
Diagnosis and Treatment Challenges: Difficult Diagnosis, Antibiotic Limitations, Controversial Post-Treatment/Chronic Lyme Disease Syndrome
The theory that Lyme disease began as a government bioweapon has circulated widely, fueled by books and political discourse. Chris Newby’s book, Bitten: The Secret History of Lyme Disease and Biological Weapons, details alleged bioweapons research at Fort Detrick, Maryland, and Plum Island, New York, during the 1950s. According to Newby, scientists investigated ticks as possible delivery systems for biological warfare, with the suggestion that disease-infected ticks could have escaped on birds migrating from these labs. The theory posits that such escapes, accidental or perhaps intentional, led to the establishment of Lyme disease in Connecticut and surrounding regions.
Adding political weight, Rep. Chris Smith from New Jersey, inspired by Newby’s claims, introduced legislation requesting a Department of Defense review into the alleged use of ticks as bioweapons by the Pentagon. This move—covered widely in the media—helped amplify the theory, even as it remains unverified.
Despite the intrigue of the bioweapon escape scenario, substantial historical evidence contradicts it. Notably, the 5,300-year-old mummy Ötzi (the Iceman), discovered in the Alps, was found to have been infected with Borrelia burgdorferi, the bacterium that causes Lyme disease. This definitively places the disease's existence millennia before modern bioweapons programs. Further, Yale researchers identified a bacterium virtually identical to modern Lyme disease in ancient North America, dating back 60,000 years—long predating human arrival.
Historically, Lyme disease did not appear in a single outbreak around Long Island or Connecticut. Instead, in the late 1960s, cases were identified in disparate locations, including California and Wisconsin (the first described U.S. case in 1969). This pattern is inconsistent with a single-point release from a lab. Moreover, the bioweapon theory is weakened by practical considerations, as Chuck Bryant notes: for such a plan to succeed, multiple unreliable contingencies (ticks escaping, finding hosts, effective transmission) would all have to unfold perfectly, and the weaponized disease is slow-acting, making it ill-suited for military purposes.
A more plausible and substantiated explanation for Lyme’s recent expansion lies in climate dynamics. The U.S. Environmental Protection Agency (EPA) officially lists Lyme disease's spread as a significant climate change indicator. Warmer winters mean far fewer ticks die off, enhancing survival rates and reproductive success.
Consequently, rising temperatures are driving ticks—and thus Lyme disease—farther north and into previously unaffected regions. Where ticks once concentrated mainly in the Northeast and mid-Atlantic, there are now Lyme cases in all lower 48 states and half of all U.S. counties are considered high-risk ...
Lyme's Spread: Bioweapon Conspiracy vs. Climate Change and Tick Expansion
In the 1970s, a cluster of children and adults in the Connecticut towns of Old Lyme, Lyme, and East Haddam developed unusual symptoms: swollen knees, skin rashes, headaches, and severe fatigue. The symptoms resembled juvenile arthritis and suggested an environmental cause. At the time, Lyme disease was not recognized or understood. Most medical professionals were unaware of this emerging disease, leading to frequent dismissal of concerned patients and families in the affected towns. Physicians tended to ignore patient reports, citing their lack of medical credentials and opting to pretend the illness was not real rather than admit their own uncertainty.
Amid these dismissals, two patient advocates, Polly Murray and Judith Minch—both mothers with affected family members—took on the task of investigating the disease themselves. Polly Murray, who had worked for the World Health Organization, compiled a list of 37 patients exhibiting similar symptoms. Despite this evidence, Murray and Minch faced gender-based discrimination and their findings were largely discounted by medical professionals.
Undeterred, they took their case to Yale Medical School and the Connecticut state health authorities, insisting that the outbreak was a real, urgent epidemic that warranted scientific attention. Their persistence succeeded in escalating the issue to the scientific community, making the illness impossible to ignore. Polly Murray’s advocacy became her life’s work, culminating in the book "The Widening Circle" in 1996, which chronicled the story of the disease and her fight for recognition. The episode exemplifies systemic sexism in science, where women’s contributions and warnings were marginalized despite their accuracy and impact.
Thanks to Murray and Minch’s advocacy, the mysterious illness came to the attention of Willy Bergdorfer, then the world’s leading authority on Rocky Mountain spotted fever, a bacterial infection also transmitted by ticks. At the time, Bergdorfer was based in Colorado, a hotspot for Rocky Mountain spotted fever. When contacted about the Connecticut outbreak, it had already been established—thanks to the work of Murray and Minch—that nearly every sick person recalled being bitten by ...
Discovery and Advocacy: Connecticut 1970s Outbreak, Advocates Polly Murray and Judith Minch, Willy Bergdorfer's Bacterium Identification
Download the Shortform Chrome extension for your browser
